GPCRs represent one of the most important yet technically challenging classes of drug targets, largely due to difficulties in producing stable, native like antigens and generating high-quality ...

Peer-reviewed study characterizes in vitro and ex vivo activities of novel antibody agonists generated using Abalone ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, automate, and analyse is continuing to transform the way we work and ...

Scientists have built upon BTE technology to develop new and improved recombinant and synthetic DNA versions of therapeutic antibodies that target CA9, called Persistent Multivalent T Cell Engager ...